Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Oxford Molecular

Oxford Molecular has sold its software division to Pharmacopeia of the US for £18m, and the remaining business will now be liquidated.

Oxford Molecular is selling Cambridge Discovery Chemistry to Millennium Pharmaceuticals for £35m, in order to reduce debt.

Oxford Molecular is set to acquire Chemical Design Holdings, the pharmaceutical software company, for about £6m.

Oxford Molecular is acquiring Genetics Computer and MRL Automation, two US software companies that specialise in the development of new drugs, funded by a £30m rights issue.

Oxford Molecular, the developer of software for the drugs industry, has bought three US companies - Chemical Informatics, MacVector and Health Designs.